Table 1 Demographics and baseline characteristics, working status of study population, migraine type and history
Characteristics | N = 172 | |
|---|---|---|
Age, mean (SD) | 44.2 (13.9) | |
Sex, n (%) | ||
Women | 146 (84.9) | |
Working status, n (%) | ||
Part-time employed | 61 (35.5) | |
Full-time employed | 54 (31.4) | |
Retired | 14 (8.1) | |
Sick leave/disability insurance | 11 (6.4) | |
In education/military service/civilian service | 5 (2.9) | |
Monthly migraine days, mean (SD) | 16.6 (7.2) | |
Monthly acute medication days, mean (SD) | 11.6 (7.0) | |
Migraine history of patients initiating erenumab, mean (SD) | Male | Female |
Years with headache | 33.2 (21.9) | 27.3 (14.1) |
Years since diagnosis | 14.7 (14.4) | 19.2 (14.7) |
Type of migraine according to ICHD-3, n (%) | ||
Episodic migraine (EM) | 92 (53.8) | |
Low frequency EM (LFEM), 4–7 MMD | 6 (3.5) | |
High frequency EM (HFEM), 8–14 MMD | 86 (50.3) | |
Chronic migraine (CM) | 79 (46.2) | |